Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to WARGO, JENNIFER
Item TypeName
Academic Article Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade.
Academic Article Loss of IFN-? Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
Academic Article Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Academic Article Diverse types of dermatologic toxicities from immune checkpoint blockade therapy.
Academic Article Interaction of molecular alterations with immune response in melanoma.
Academic Article VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
Academic Article Hallmarks of response to immune checkpoint blockade.
Academic Article Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients.
Academic Article Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.
Academic Article Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers.
Academic Article Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Academic Article Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Concept Ipilimumab
Academic Article Neoadjuvant therapy for melanoma: is it ready for prime time?
Academic Article Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Academic Article Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Academic Article Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1.
Academic Article Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Academic Article Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Search Criteria
  • Ipilimumab